Title: Research progress of application of immunotherapy by chimeric antigen receptor-engineered T cells
Abstract: The technique of chimeric antigen receptor-engineered T cells (CAR-T) is combined single chain antibody and T-cell activation modification and has specific and durable killing effect on tumors. It had achieved stunning results on clinical trials of B lymphocytic leukemias, B lymphomas and solid tumors. Meanwhile it also had potential risk on the off target effects, cytokine release syndrome, graft versus host disease and so on. This paper briefly reviews the principal of CAR-T cellular mechanism, advantages and clinical applications.
Key words:
Adoptive immunotherapy; Chimeric antigen receptor; Cancer immunotherapy
Publication Year: 2015
Publication Date: 2015-02-28
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot